project id: TCGA-OV; case submitter id: TCGA-13-2066; source center: 22; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.9; rna integrity number: 6.5; spectrophotometer method: UV Spec; age at index: 49; days to birth: -18170; days to death: 2133; ethnicity: hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1960; age at diagnosis: 18170; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 295.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.5; longest dimension: 2.0; preservation method: Unknown; shortest dimension: 0.3; sample id: 9f643408-6b72-475c-acc5-76ae22fcc143; sample submitter id: TCGA-13-2066-01A; portion id: 2c90247f-8abb-4c34-81a5-676da8ce8052; portion submitter id: TCGA-13-2066-01A-01; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;